Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index; 4 of the 13 sources its claims cite were checked for support.
Abstract
AIMS: Neointimal hyperplasia (NIH) characterized by vascular smooth muscle cell (VSMC) dysfunctions plays a critical role in many vascular diseases including atherosclerosis and restenosis, which leads to serious ischaemic complications and has limited therapeutic approaches. Our previous studies confirm a critical role for nuclear factor erythroid 2-related factor 3 (Nrf3) in VSMC differentiation. However, little is known about the functional implications of Nrf3 in NIH. METHODS AND RESULTS: Transcriptome dataset and human atherosclerotic samples were used to determine Nrf3 expression levels. Global (Nrf3-/-) and VSMC-specific (Nrf3ΔSMC) Nrf3 knockout mice were used to assess the role of Nrf3 in VSMC function and injury-induced NIH. Complementary molecular methods were performed to identify Nrf3 downstream targets and elucidate the regulatory role of Nrf3 in target gene regulation. Porcine carotid stenting model was used to validate the therapeutic effects of Nrf3 inhibition in vascular remodelling. Transcriptomic data and immunostaining analysis showed increased levels of Nrf3, and a positive correlation between Nrf3 and NIH in the human atherosclerotic vessels. Various pathophysiological stimuli induced endoplasmic reticulum stress that enhanced Nrf3 expression via Activating Transcription Factor 4 (ATF4). Nrf3 overexpression promoted both human and mouse VSMC proliferation, migration, and inflammatory response, while opposite effects were observed when Nrf3 was deleted or knockdown. Nrf3-/- and Nrf3ΔSMC mice showed decreased VSMC accumulation and attenuated vascular injury-induced NIH. Mechanistically, tripartite motif-containing 5 (Trim5), a genetic risk locus for coronary artery disease, was identified as a functional downstream target of Nrf3 in VSMCs and in injured arteries. Nrf3 enhanced autophagy in VSMCs and injured arteries by up-regulating Trim5 expression, which subsequently promoted dysfunctions of VSMCs, thereby increasing injury-induced NIH. Importantly, restoring either Nrf3 or Trim5 expression in Nrf3-/- mice rescued the arterial phenotypes observed in Nrf3-/- mice. Critically, the porcine carotid artery restenosis induced by ballooning and stenting was significantly reduced by suppressing Nrf3 expression through perivascular administration of the Nrf3 inhibitors. CONCLUSIONS: We comprehensively demonstrate that Nrf3 is a novel modulator in VSMC dysfunctions and injury-induced NIH. Nrf3 exerts its pathological functions by transcriptional activation of Trim5 gene, which in turn triggers autophagy in VSMCs and injured arteries, promoting arterial remodelling. Inhibiting the Nrf3-Trim5 signal axis ameliorates injury-induced NIH, offering novel therapeutics for treating patients with NIH-related vascular diseases.
Overview
CoChat Summary
TL;DR
Nrf3 is upregulated in human atherosclerotic lesions and injury-induced neointima, where ER stress/ATF4 induces its expression; Nrf3 transcriptionally activates Trim5, which binds BECN1 to promote autophagy and VSMC proliferation, migration, and inflammation. Genetic deletion or AAV9-mediated inhibition of Nrf3 reduces neointimal hyperplasia in mouse injury models and stent-induced restenosis in pigs, implicating the Nrf3–Trim5 axis as a therapeutic target.
Key findings
- Nrf3 expression was significantly higher in human carotid, femoral, and infra-popliteal atherosclerotic lesions versus normal arteries in GSE100927; in 30 diseased femoral arterial (DFA) and 30 healthy femoral arterial (HFA) specimens, Nrf3 was abundant in the VSMC-rich neointimal region and positively associated with enlarged neointima area and higher neointima/media ratio.
- Pathophysiological stimuli (FBS, PDGF-BB, TNF-α, ox-LDL) increased Nrf3 transcript/protein in mouse and human VSMCs; ER stress marker Grp78 increased, ATF4 silencing decreased Nrf3, and ChIP plus luciferase assays confirmed ATF4 binding to the Nrf3 promoter.
- Nrf3 overexpression promoted VSMC proliferation, migration, and inflammatory response, while Nrf3 deletion/knockdown reduced these. In wire injury, Nrf3−/− and Nrf3ΔSMC mice had decreased neointimal area (0.011 ± 0.001 mm² in Nrf3−/− vs. 0.011 ± 0.001 mm² in Nrf3ΔSMC vs. 0.016 ± 0.001 mm² in WT) and neointima/media ratio (0.96 ± 0.12 vs. 1.02 ± 0.08 vs. 1.47 ± 0.19); AAV9-Nrf3 restoration increased neointimal area (0.016 ± 0.001 vs. 0.010 ± 0.001 mm²) and ratio (1.47 ± 0.18 vs. 0.93 ± 0.10).
- Trim5 was downregulated in Nrf3−/− arteries; Nrf3 directly bound the Trim5 promoter and increased Trim5 expression. Nrf3–Trim5 promoted autophagy (BECN1/LC3B, autophagosomes/autolysosomes, autophagic flux), and Trim5 knockdown abolished Nrf3 effects. Restoring Trim5 in Nrf3−/− mice rescued injury-induced neointima area and ratio. In porcine carotid stenting, perivascular AAV9-shNrf3 reduced Nrf3, Trim5, LC3B, CD68+, Ki67+, neointima area, and neointima/media ratio versus AAV9-Scr.
Methods
- Human data: GSE100927 transcriptomic dataset, GWAS Catalog GCST90132314, and 30 DFA plus 30 HFA specimens; ethical approval from the First Affiliated Hospital of Zhejiang University School of Medicine.
- Mouse experiments: global Nrf3−/− and VSMC-specific Nrf3ΔSMC mice generated from Nrf3flox/flox; femoral artery wire injury and carotid artery ligation; AAV9-Nrf3 or AAV9-Trim5 rescue; RNA-seq analyzed with DESeq2; histology, immunofluorescence, FISH; primary mouse aortic VSMCs (P5–P8) and human VSMC line; ChIP, luciferase reporter, co-immunoprecipitation, transmission electron microscopy, and Cyto-ID autophagy assays.
- Porcine experiments: Chinese domestic pigs (40–60 kg) with bare metal stent implantation into external carotid arteries; digital subtraction angiography every 30 days and histology at Day 90; perivascular AAV9-shNrf3 versus AAV9-Scr. Statistics: means ± S.E.M.; two-tailed Student’s t-test, one-way ANOVA with Bonferroni or Tamhane’s T2, Mann–Whitney, or Kruskal–Wallis with Dunn’s test; P < 0.05; SPSS version 19.0.
Limitations
- Stated: only male mice were used because of hormonal fluctuations in female mice during the oestrous cycle; this limits broader implication and clinical translation, and future validation in females is needed.
- Stated: the AAV9 CMV promoter caused Nrf3 overexpression in other tissues, particularly liver, indicating potential off-target effects; future studies should use more tissue-targeted promoters such as smooth muscle-specific promoters.
- Stated: further investigation is needed into Nrf3 in lipid-driven atherosclerotic plaque development/progression, other signalling pathways that may regulate Nrf3, and the role of the PERK-ATF4 pathway in vascular remodelling.
- Evident from the text (not framed as limitations by the authors): human validation used 30 DFA and 30 HFA specimens plus public datasets; mouse experiments used only male mice; the porcine study reports a 90-day endpoint.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 5 Nrf3 modulates VSMC functions through Trim5-mediated autophagy. (A–E) VSMCs were co-transfected with non-targeting control (Si-NT) or Trim5-specific (Si-Trim5) siRNAs and control (Ad-Scr) or Nrf3 overexpression (Ad-Nrf3) vectors as indicated. After 24 h of serum starvation, cells were treated with PDGF-BB (10 ng/mL) for 24 h, followed by RT–qPCR (A), EdU (B), CCK8 (C), trans-well migration (D), and western blot (E) assays, respectively (n = 4–6). (F) VSMCs were co-transfected with Ad-GFP-mCherry-LC3B, Si-Trim5, and Ad-Nrf3 (or their respective negative control: si-NT or Ad-Scr) as indicated, and treated with PDGF-BB (10 ng/mL). Cells were fixed and stained with DAPI, followed by confocal microscopy analysis. Representative images (left) (scale bars: 10 μm) and statistical analyses of autophagosome (AP) and autolysosome (ASS) numbers per cell (right) were presented (n = 6). (G) Transmission electron microscope (TEM) analysis of AP and ASS numbers in VSMCs. Representative images (left) [scale bars: 5 μm (up) and 1 μm (down)] and statistical analyses of AP/ASS number per cell (right) were showed (n = 6–8). (H) Cyto-ID Green and Hoechst were used for staining and detecting autophagy vesicles in live cells. Representative images (left) (scale bars: 50 μm) and statistical analyses of mean fluorescence intensity (MFI) over DAPI (right) were presented (n = 6). (I) Protein-dock analysis to predict the structure of TRIM5–BECN1 protein complex and their potential binding site. (J) Co-immunoprecipitation (Co-IP) assays. VSMCs were infected with Ad-Trim5-flag for 48 h, and subsequently treated with PDGF-BB (10 ng/mL) for 24 h. Cell lysates were immunoprecipitated with IgG or anti-Flag, followed by western blot assay to detect the interaction between Trim5 and BECN1. ‘+’ indicates overexpression of Nrf3 or knockdown of Trim5, such as Ad-Nrf3 or Si-Trim5. ‘−’ represents the corresponding control, such as Ad-Scr or Si-NT. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by two-way ANOVA test (A–H). *P < 0.05; ‘ns’ denotes non-significant differences.](https://figures.cochat.ai/paper-figures/0c5226a7d3ec475bb7ac9e6cad430799/novel-roles-of-nrf3trim5-axis-in-vascular-smooth-muscle-cell-dysfunctions-and-figure-5.jpg)
![Figure 6 Functional importance of Trim5-mediated autophagy in Nrf3-mediated injury-induced NIH. (A and B) Increased Trim5 expression in injured arteries as detected by RT–qPCR (A) and immunofluorescence (IF) staining (scale bars: 20 μm) (B) analysis, respectively (n = 5–7). (C and D) RT–qPCR (C) and IF staining (scale bars: 20 μm) (D) analysis showing decreased Trim5 expression in injured arteries of Nrf3−/− mice (scale bars: 50 μm) (n = 6–8). (E) IF staining analysis of Trim5 expression in control littermates (Nrf3f/f), Nrf3−/−+AAV9-Scr (control), and Nrf3−/−+AAV9-Nrf3 mice (scale bars: 20 μm) (n = 5). (F) IF staining analysis of LC3B expression in injured femoral arteries at Day 7 of Nrf3f/f and Nrf3−/− mice (scale bars: 50 μm) (n = 7). (G) Transmission electron microscope (TEM) analysis of autophagy (AP and ASS numbers) in sham (FA) or injured femoral arteries (FAI) of Nrf3f/f and Nrf3−/− mice [scale bars: 2 μm (left) and 1 μm (right)] (n = 6–8). (H and I) IF staining analysis of Ki67, CD68, and CD45 positive cells (%) in wire injured femoral arteries at Day 7 of Nrf3f/f and Nrf3−/− mice (scale bars: 50 μm) (n = 8). Data included in (B, D–I) are representative images (left) and statistical analyses of relative mean fluorescence intensity (MFI) of target protein(s) over DAPI (B, D–F), AP&ASS numbers (G), or cell percentage (%, H and I). (J) Restoring Trim5 in Nrf3−/− mice rescued the phenotypes observed in Nrf3−/− mice. Nrf3f/f or Nrf3−/− mice were randomly administrated with control (AAV9-Scr) or Trim5 overexpressing (AAV9-Trim5) vector as indicated. Three weeks later, mice were subjected to FAI procedures. Injured vessels were collected at four weeks post-injury and subjected to HE staining analysis (n = 9 mice per group). (K) Autophagy inhibition reversed Nrf3-mediated NIH. Nrf3−/− mice were randomly injected with AAV9-Scr or AAV9-Nrf3. Three weeks later, mice were either subjected to sham or FAI procedures, followed by randomly administrated with vehicle control (sterile PBS) or chloroquine (CQ, 50 mg/kg, ip injection) on a daily basis. Four weeks after injury, vessels were collected and subjected to HE staining analysis (n = 6–7 mice per group). Data showed here are representative images (left) and statistical analyses of neointima area, media area, and ratio of neointima/media (right), respectively. Data and error bars represent the mean ± S.E.M. Statistical analysis was performed by Student’s t-test (A–D, F, H, I) or one-way ANOVA test (E, G, J, K). *P < 0.05; ‘ns’ denotes non-significant differences.](https://figures.cochat.ai/paper-figures/50d0f525521d4319b0ea85fd2991d060/novel-roles-of-nrf3trim5-axis-in-vascular-smooth-muscle-cell-dysfunctions-and-figure-6.jpg)

Verification
Claims the paper makes
3 Valid · 0 Not valid · 7 Not checked · 134 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“We have previously showed that Nrf3 expression is regulated by endoplasmic reticulum (ER) stress.15”
§ Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia > Results > Nrf3 is induced transcriptionally via endoplasmic reticulum stress in the VSMCs
What the sources say
- Supportedcites [15] Pepe, 2010, Crucial role of Nrf3 in smooth muscle cell differentiation from stem cells, Circ Res source
The Results section 'Nrf3 Is Involved in Endoplasmic Reticulum Stress-Inducer-Mediated SMC Differentiation' states that treating day-2 differentiating ESCs with increasing concentrations of the ER stress inducer thapsigargin produced a dose-dependent upregulation of Nrf3 (and SMC markers), and the Discussion restates 'Our data showed that thapsigargin treatment increases the expression of Nrf3'; Figure 6 legend summarises the panel as 'Nrf3 is involved in ER stress.' The claim is thus supported, bounded in the source to the thapsigargin/ER-stress-inducer setting in differentiating embryonic stem cells — the same Discussion notes that a second ER inducer, tunicamycin, had no effect on Nrf3 activity in their system (contrary to Zhang et al. 2009 in COS-1 cells), so the regulation is demonstrated with one ER stressor rather than ER stress universally. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Critically, the porcine carotid artery restenosis induced by ballooning and stenting was significantly reduced by suppressing Nrf3 expression through perivascular administration of the Nrf3 inhibitors.”
§ Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia > Abstract > Methods and results
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Importantly, restored Nrf3 expression in the Nrf3−/− mice significantly increased the neointimal area (0.016 ± 0.001 mm2 in AAV9-Nrf3 vs. 0.010 ± 0.001 mm2 in AAV9-Scr) and neointima/media ratio (1.47 ± 0.18 in AAV9-Nrf3 vs. 0.93 ± 0.10 in AAV9-Scr) (Figure 3E and F).”
§ Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia > Results > Inhibition of Nrf3 attenuates vascular injury-induced NIH in the mouse models
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Moreover, compared with WT VSMCs, the expression levels of ICAM-1, IL-6, and IL-12β, which are critical in vascular inflammation and remodelling, were significantly reduced in the Nrf3−/− VSMCs when stimulated with TNF-α (Figure 2E–G).”
§ Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia > Results > Nrf3 promotes proliferation, migration, and inflammatory response of the VSMCs
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Silencing of ATF4 in the VSMCs significantly decreased Nrf3 mRNA and protein expression levels (see Supplementary material online, Figure S2J–L).”
§ Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia > Results > Nrf3 is induced transcriptionally via endoplasmic reticulum stress in the VSMCs
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
103 more claims
Create a free account to see all 144 claims and to verify the 9 references still open.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 30
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Then, they reported that NRF3 knockdown decreased proliferation, migration, and inflammatory responses of human and murine VSMCs under PDGF-BB, TNF-α, and ox-LDL pathological stimuli.”
From Targeting autophagy to treat neointimal hyperplasia in vascular disease (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This autophagy activation promotes vascular smooth muscle cell phenotypic switching, characterized by enhanced proliferation, migration, and inflammation, ultimately driving neointimal hyperplasia.”
From Targeting autophagy to treat neointimal hyperplasia in vascular disease (2025) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ATF4 transcriptionally activates NRF3, triggering its upregulation to induce TRIM5 expression, a recently identified genetic risk locus for coronary artery disease, and promoted TRIM5/BECN1-induced VSMC autophagy in response to pathological stimuli or vascular injury 6 .”
From Targeting autophagy to treat neointimal hyperplasia in vascular disease (2025) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“TRIM5 recruits BECN1 and assembles a functional complex to initiate autophagosome formation.”
From Targeting autophagy to treat neointimal hyperplasia in vascular disease (2025) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“Restoration of NRF3 expression in the vascular wall using an AAV9 delivery system in NRF3 global knockout mice increased the neointimal area, which was prevented by administration of the autophagy inhibitor chloroquine, confirming the critical for autophagy in NRF3-mediated VSMC proliferation and migration 6 .”
From Targeting autophagy to treat neointimal hyperplasia in vascular disease (2025) · cites this paper as [6]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Tang, Z., Li, C., Kang, B., Gao, G., Li, C., & Zhang, Z. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx247 · Cited by 9,849 · cited 2×
“12 Evidence also suggests that Nrf3 may play a key role in cardiovascular diseases because it inhibits lipogenesis and regulates cholesterol biosynthesis and uptake.”
The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924 · cited 2×
“32 ER stress is a common cell stress response mechanism that is activated as an adaptive response to physiological changes as well as in diseases involving vascular injury and remodelling.”
The changing landscape of atherosclerosis
Libby, P. (2021) · Nature · doi:10.1038/s41586-021-03392-8 · Cited by 2,873
van der Harst, P., & Verweij, N. (2018) · Circulation Research · doi:10.1161/circresaha.117.312086 · Cited by 1,141 · cited 1×
“A recent GWAS study by van der Harst et al. 37 identified 64 novel genetic risk loci for CAD, including Trim5 (rs11601507), by analysing a large cohort from the UK Biobank, including 34 541 CAD cases and 261 984 controls, and the CARDIoGRAMplusC4D dataset with 88 192 CAD cases and 162 544 controls.”
Vascular smooth muscle cells in atherosclerosis
Basatemur, G. L., Jørgensen, H. F., Clarke, M. C. H., Bennett, M. R., & Mallat, Z. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0227-9 · Cited by 1,099
Autophagy and mitophagy in cardiovascular disease
Bravo-San Pedro, J. M., Kroemer, G., & Galluzzi, L. (2017) · Circulation Research · doi:10.1161/circresaha.117.311082 · Cited by 843 · cited 2×
“4,5 Autophagy is a subcellular process that is responsible for the degradation and recycling of proteins and organelles in response to cellular stress.”
Zhang, Q., Liu, J., Duan, H., Li, R., Peng, W., & Wu, C. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.06.023 · Cited by 829 · cited 1×
“8 Both Nrf2 and Nrf1 play a critical role in the cardiovascular system.”
Aragam, K. G., Jiang, T., Goel, A., Kanoni, S., Wolford, B. N., Atri, D. S., Weeks, E. M., Wang, M., Hindy, G., Zhou, W., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01233-6 · Cited by 723
Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases
Ren, J., Bi, Y., Sowers, J. R., Hetz, C., & Zhang, Y. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00511-w · Cited by 708 · cited 1×
“4,5 Autophagy is a subcellular process that is responsible for the degradation and recycling of proteins and organelles in response to cellular stress.”
Modulating NRF2 in Disease: Timing Is Everything
Dodson, M., de la Vega, M. R., Cholanians, A. B., Schmidlin, C. J., Chapman, E., & Zhang, D. D. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021856 · Cited by 522 · cited 1×
“23,24 However, the biological function of Nrf3 is less clear since Nrf3-deficient mice display no overt signs of any abnormalities under physiological conditions.”
Cited by
Hou, D., Yang, K., Liu, Y., Du, H., Yue, H., Xu, F., Sang, W., Zhao, X., Sun, Y., Xu, F., et al. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156411 · Cited by 2
ATF4 in cardiovascular diseases: an emerging therapeutic target
Qin, L., Chen, R., Huang, C., Wang, X., Song, Q., Li, Z., Xu, X., Liu, Z., Wang, B., Li, B., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117703 · Cited by 3
Self-citationTargeting autophagy to treat neointimal hyperplasia in vascular disease
Yan, R., Tual-Chalot, S., & Stellos, K. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf104 · Cited by 1
Emerging Role and Potential Therapeutic Application of TRIM Proteins in Cardiovascular Diseases
Cui, Y., Wen, Y., Wang, X., Xu, Y., & Jiang, M. (2026) · Biomolecules · doi:10.3390/biom16050676 · Cited by 1
“Their study showed that TRIM5 bound to BECN1 to drive pathological autophagy, which, contrary to its typically protective role, promoted VSMC proliferation, migration, and inflammation in this context, ultimately exacerbating neointimal hyperplasia [133].”
Research Progress on Clinical Efficacy of Drug Balloon in Patients with In-Stent Restenosis
杜, 磊. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.161057
Metadata
- Authors
- Chen, Q., Sun, S., Shi, Z., Wang, L., Wang, Y., Zheng, A., Xu, X., Yang, M., Sun, K., Xiao, Q., & Zhang, L.
- Affiliations
- Queen Mary University of London (GB)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Xiao, Qingzhong
- Zhang, Li
- ORCID
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2025-05-16
- Volume
- 121
- Issue
- 8
- Pages
- 1282-1298
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC12310284
- OpenAlex
- W4410419044
- Cited by
- 5
- References
- 55
- Citations by year
- 2026: 3 · 2025: 2
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cardiovascular Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Key R&D Program of China (2022YFA1104200)
- National Natural Sciences Foundation of China (82270430, 82125005, 82100503, 81930010)
- Zhejiang Provincial Natural Science Foundation (LR20H020001)
- Shanghai Natural Science Foundation (22ZR148000)
- British Heart Foundation (PG/15/11/31279, PG/15/86/31723, PG/20/10458, PG/23/11371)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- Nrf3, TRIM5, intimal hyperplasia, vascular smooth muscle cells, restenosis, atherosclerosis, endoplasmic reticulum stress, ATF4, autophagy, vascular remodeling, carotid artery stenting, inflammation, knockout mice, transcriptomics
- MeSH terms
- Animals, Carotid Artery Diseases, Cells, Cultured, Disease Models, Animal, Humans, Hyperplasia, Male, Mice, Inbred C57BL, Muscle, Smooth, Vascular, Signal Transduction, Mice, Knockout, Carotid Artery Injuries, Myocytes, Smooth Muscle, Ubiquitin-Protein Ligases, Cell Proliferation, Mice, Neointima, Vascular Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia. https://app.cochat.ai/papers/10.1093/cvr/cvaf084
- The paper
- Chen, Q., Sun, S., Shi, Z., Wang, L., Wang, Y., Zheng, A., Xu, X., Yang, M., Sun, K., Xiao, Q., & Zhang, L. (2025). Novel roles of Nrf3–Trim5 axis in vascular smooth muscle cell dysfunctions and neointimal hyperplasia. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf084
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.